glp-1 for long covid Inside the Study COVID, with lead scientist Dr Julia Vogel, Long Covid, MD Pod, Ep 61 Anti-inflammatory effects of GLP-1 in
Description
This level of fatigue might indicate that adjustments to your treatment plan are necessary

Glucagon-like peptide-1 (GLP-1) is an incretin that increases insulin sensitivity and aids glucose metabolism

NHS treatment includes specific stopping rules (minimum weight loss thresholds at review points) and typically has a maximum treatment duration of 2 years

Obesity: the disease of the twenty-first century

A recent cohort study involving 200 IBD patients identified visceral adiposity, rather than BMI, as a predictive risk factor for a shorter time to IBD flare, particularly for CD patients (90)

Patients should contact their GP or healthcare provider if they experience: Dark or concentrated urine accompanied by reduced urine output, which may indicate dehydration requiring intervention Foul-smelling urine with dysuria (painful urination), frequency, urgency, or suprapubic pain, which may suggest a urinary tract infection Sweet or fruity-smelling urine combined with excessive thirst, frequent urination, nausea, vomiting, or abdominal painparticularly in patients with diabetes, as these may indicate diabetic ketoacidosis requiring emergency care (call 999 or attend A&E) Blood in the urine (haematuria) or pain during urination, which requires investigation Fever or flank pain with urinary symptoms, which could indicate pyelonephritis (kidney infection) Urinary tract infections (UTIs) can occur independently of Saxenda treatment
